Evaluation of Serum Fibroblast Growth Factor 23 for Cardiovascular Risk Prediction in Chronic Kidney Disease Patients: A Study Using the SCORE2 Risk Model. Int. J. Environ. Sci. 2025, 11 (12s), 1360-1367. https://doi.org/10.64252/8crhea08.